Release Characteristics of Quetiapine Fumarate Extended Release Tablets Under Biorelevant Stress Test Conditions
Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media
Application of biorelevant dissolution tests to the prediction of performance of diclofenac sodium from an oral modified-release pellet dosage form
Development and Application of a Biorelevant Dissolution Method Using USP Apparatus 4 in Early Phase Formulation Development
Designing biorelevant dissolution tests for lipid formulations: Case example – Lipid suspension of RZ-50
